Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV combination vaccine Co-administered with a hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age

Giovanni Gabutti From the Laboratory of Hygiene, Di.S.Te.B.A., University of Lecce, Verona, ItalyCorrespondence[email protected]

Fred Zepp Kinderklinik Johannes-Gutenberg, University of Mainz, Germany

Lode Schuerman GlaxoSmithKline Biologicals, Rixensart, Belgium

Pietro Dentico Department of Clinical Medicine, Immunology and Infectious Diseases, Chair of Tropical Medicine, University of Bari, Verona, Italy

Francesco Bamfi Medical Directorate and Former Medical Directorate, GlaxoSmithKline, Verona, GlaxoSmithKline, Verona, Italy

Renato Soncini Medical Directorate and Former Medical Directorate, GlaxoSmithKline, Verona, GlaxoSmithKline, Verona, Italy

Peter Habermehl Kinderklinik Johannes-Gutenberg, University of Mainz, Germany

Markus Knuf Kinderklinik Johannes-Gutenberg, University of Mainz, Germany

Pietro Crovari Department of Health Sciences, Hygiene and Preventive Medicine Section, University of Genova, Verona, Italy

Your download is now in progress and you may close this window